Dr Alan Taylor has a background as a scientist, investment banker, entrepreneur and investor. Alan is currently very active in the Australian start-up area, investing in, advising and taking an active role within a number of early stage companies. Alan is currently the executive chairman at Clarity Pharmaceuticals, a company focused on developing radiopharmaceuticals for the treatment of cancer and other diseases.
Alan is also the chairman and co-founder of Mizzen Group Pty Ltd, a new technology start-up company. Alan is passionate about the commercialisation of Australian science and technologies, either in general technology or the life sciences.
Alan has approximately 10 years of investment banking experience, and was until recently an executive director and shareholder of Inteq Limited, a boutique Australian investment bank, where he remains on the Board of Directors. Alan has significant experience in capital raisings, mergers and acquisitions, and general corporate advisory. At Inteq, Alan was involved in some of the largest ever medical device transactions in Australia.
Alan completed an undergraduate degree in Applied Science at the University of Sydney, where he finished first in his year and won the prestigious University Medal. He completed his Ph.D. in Medicine at the Garvan Institute of Medical Research.